Nivolumab (active substance) - analogs
Pharmgroups: Antitumor agents - monoclonal antibodies |
|||||||||
| Prices in pharmacies: Instructions Nivolumab | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 69% Atezolizumab
- 66% Ramucirumab
- 65% Trastuzumab deruxtecan
- 64% Trastuzumab emtansine
- 62% Panitumumab
- 62% Camrelizumab
- 59% Pembrolizumab
- 57% Erlotinib
- 52% Cetuximab
- 50% Nintedanib
- 48% Trastuzumab
- 48% Selpercatinib
- 47% Bevacizumab
- 46% Cabozantinib
- 43% Pemetrexed
- 42% Trametinib
- 41% Encorafenib
- 40% Idarubicin
- 38% Ipilimumab
- 38% Elotuzumab
- 37% Axitinib
- 35% Sunitinib
- 35% Vinorelbine
- 35% Lorlatinib
- 35% Durvalumab
- 35% Isatuximab
- 33% Pertuzumab
- 33% Hydrazine sulfate
- 33% Dipin
- 33% Catumaxomab
- 33% Tremelimumab
- 32% Palonosetron
- 32% Docetaxel
- 32% Abemaciclib
- 32% Eribulin
- 32% Alectinib
- 32% Dabrafenib+Trametinib [set] [Dabrafenib and more 1Trametinib]
- 31% Vindesine
- 31% Lenograstim
- 31% Brentuximab Vedotin
- 31% Gallium [67Ga] citrate
- 31% Prolgolimab
- 31% Lipegfilgrastim
- 30% Daratumumab
- 30% Proxifeine
- 29% Etoposide
- 29% Vismodegib
- 29% Temozolomide
- 29% Dexrazoxane
- 29% Molgramostim
Learn more about the selection of analogues
▶
- The drug has «Nivolumab» 51 analog by action, the most similar - Atezolizumab .
- Medical online service has selected the best substitutes for Nivolumab based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Nivolumab to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.